EP1631289A4 - ANTI-HIV BENZAMIDE COMPOUNDS - Google Patents

ANTI-HIV BENZAMIDE COMPOUNDS

Info

Publication number: EP1631289A4
Authority: EP; European Patent Office
Prior art keywords: hiv; benzamide compounds; benzamide; compounds; hiv benzamide
Prior art date: 2003-06-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP04752748A

Other languages

German (de)

French (fr)

Other versions

EP1631289A2 (en

Inventor

Vassilios Papadopoulos

Janet Greeson

Laurent Lecanu

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Georgetown University

Samaritan Pharmaceuticals Inc

Original Assignee

Georgetown University

Samaritan Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-02

Filing date

2004-05-20

Publication date

2010-06-02

2004-05-20 Application filed by Georgetown University, Samaritan Pharmaceuticals Inc filed Critical Georgetown University

2006-03-08 Publication of EP1631289A2 publication Critical patent/EP1631289A2/en

2010-06-02 Publication of EP1631289A4 publication Critical patent/EP1631289A4/en

Status Withdrawn legal-status Critical Current

Links

KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical class NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 title 1
230000036436 anti-hiv Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Virology (AREA)
Epidemiology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

EP04752748A 2003-06-02 2004-05-20 ANTI-HIV BENZAMIDE COMPOUNDS Withdrawn EP1631289A4 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US47496403P	2003-06-02	2003-06-02
US47564203P	2003-06-04	2003-06-04
US47864803P	2003-08-01	2003-08-01
US56463604P	2004-04-22	2004-04-22
PCT/US2004/015791 WO2004108076A2 (en)	2003-06-02	2004-05-20	Anti-hiv benzamide compounds

Publications (2)

Publication Number	Publication Date
EP1631289A2 EP1631289A2 (en)	2006-03-08
EP1631289A4 true EP1631289A4 (en)	2010-06-02

Family

ID=33514877

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP04752748A Withdrawn EP1631289A4 (en)	2003-06-02	2004-05-20	ANTI-HIV BENZAMIDE COMPOUNDS

Country Status (5)

Country	Link
EP (1)	EP1631289A4 (en)
JP (1)	JP2006526633A (en)
AU (1)	AU2004244982A1 (en)
CA (1)	CA2527211A1 (en)
WO (1)	WO2004108076A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2534777A1 (en) *	2003-08-05	2005-02-24	Samaritan Pharmaceuticals Inc.	Sigma-1 receptor ligand with acetylcholinesterase inhibition properties
US20080194619A1 (en) *	2004-04-05	2008-08-14	Laurent Lecanu	Anti-Hiv Quinuclidine Compounds

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001096304A1 (en) *	2000-06-13	2001-12-20	Eli Lilly And Company	Serine protease inhibitors
WO2002032871A2 (en) *	2000-10-17	2002-04-25	The Procter & Gamble Company	Compounds and methods for treating multidrug resistance
WO2005000205A2 (en) *	2003-06-02	2005-01-06	Samaritan Pharmaceuticals, Inc.	Methods and compositions for modulating serum cortisol levels

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1279843A (en) *	1969-05-23	1972-06-28	Science Union & Cie	Benzamidoethyl-piperazines and process for their preparation
JP2769578B2 (en) *	1989-10-13	1998-06-25	大塚製薬株式会社	Vasopressin antagonist
DE4302485A1 (en) *	1993-01-29	1994-08-04	Merck Patent Gmbh	Piperazine derivatives
US6339087B1 (en) *	1997-08-18	2002-01-15	Syntex (U.S.A.) Llc	Cyclic amine derivatives-CCR-3 receptor antagonists
IL125658A0 (en) *	1997-08-18	1999-04-11	Hoffmann La Roche	Ccr-3 receptor antagonists

2004
- 2004-05-20 WO PCT/US2004/015791 patent/WO2004108076A2/en not_active Ceased
- 2004-05-20 CA CA002527211A patent/CA2527211A1/en not_active Abandoned
- 2004-05-20 AU AU2004244982A patent/AU2004244982A1/en not_active Abandoned
- 2004-05-20 EP EP04752748A patent/EP1631289A4/en not_active Withdrawn
- 2004-05-20 JP JP2006514907A patent/JP2006526633A/en active Pending

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001096304A1 (en) *	2000-06-13	2001-12-20	Eli Lilly And Company	Serine protease inhibitors
WO2002032871A2 (en) *	2000-10-17	2002-04-25	The Procter & Gamble Company	Compounds and methods for treating multidrug resistance
WO2005000205A2 (en) *	2003-06-02	2005-01-06	Samaritan Pharmaceuticals, Inc.	Methods and compositions for modulating serum cortisol levels

Also Published As

Publication number	Publication date
CA2527211A1 (en)	2004-12-16
AU2004244982A1 (en)	2004-12-16
WO2004108076A2 (en)	2004-12-16
WO2004108076A3 (en)	2005-12-29
EP1631289A2 (en)	2006-03-08
JP2006526633A (en)	2006-11-24

Legal Events

Date	Code	Title	Description
2006-01-20	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2006-03-08	17P	Request for examination filed	Effective date: 20051214
2006-03-08	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
2006-03-08	AX	Request for extension of the european patent	Extension state: AL HR LT LV MK
2006-09-06	DAX	Request for extension of the european patent (deleted)
2010-06-02	A4	Supplementary search report drawn up and despatched	Effective date: 20100504
2010-06-02	RIC1	Information provided on ipc code assigned before grant	Ipc: A61P 31/18 20060101ALI20100427BHEP Ipc: A61P 31/00 20060101ALI20100427BHEP Ipc: A61K 31/33 20060101ALI20100427BHEP Ipc: A61K 31/497 20060101AFI20060105BHEP
2011-01-21	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2011-02-23	18D	Application deemed to be withdrawn	Effective date: 20100823

Publication	Publication Date	Title
BR0313322B1 (en)	2013-09-17	Toothbrush
DK1563100T3 (en)	2013-08-05	Displacement sandwich-immuno-PCR
DE602004006644D1 (en)	2007-07-05	TEETH ELASTIC ACID
EP1477118A4 (en)	2010-08-04	ultrasonograph
EP1500371A4 (en)	2011-07-27	ULTRASONOGRAPH
FI20030007A0 (en)	2003-01-02	Dispenser or collector
ATA1782003A (en)	2003-10-15	DETACHABLE SNAP CONNECTION
DE60328353D1 (en)	2009-08-27	Inertia
DE60315063D1 (en)	2007-08-30	ELEKTROKONTAKT ELEMENT
DK1492934T3 (en)	2010-10-04	Set as
DE602004004176D1 (en)	2007-02-22	implement
DE502004006636D1 (en)	2008-05-08	connecting element
EP1500370A4 (en)	2006-08-02	ultrasonograph
FI20022005A7 (en)	2004-05-09	Connecting piece
DE602004012938D1 (en)	2008-05-21	photocoupler
BR0311793B1 (en)	2013-12-31	NEBLINA PROJECTIL
DE60236534D1 (en)	2010-07-08	IMPROVED HERBICIDAL COMPOSITION
EP1377281A4 (en)	2009-06-17	TAURINE COMPOUNDS
DE50302582D1 (en)	2006-05-04	Snap-ball stud
FR2861758B1 (en)	2009-01-16	CANIVEAU ELEMENT
ITMI20042063A1 (en)	2005-01-29	JOINT
EP1658301A4 (en)	2009-12-09	N-DESMETHYL-11-DESOXYERYTHROMYCIN-N-SUBSTITUTED COMPOUNDS
EP1631289A4 (en)	2010-06-02	ANTI-HIV BENZAMIDE COMPOUNDS
ATE357603T1 (en)	2007-04-15	FASTENING ARRANGEMENT
FR2844817B1 (en)	2008-06-13	FORMING ELEMENT